Related Experiment Video
Updated: Apr 29, 2026
06:28
A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood
Published on: August 12, 2016
16.1K
Update on metabolic issues in HIV patients
Marta Calvo1, Esteban Martinez
1Hospital Clínic-IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
Current Opinion in HIV and AIDS
|May 15, 2014
Summary
Aging HIV patients face increased risks of metabolic issues like high triglycerides and insulin resistance due to HIV and its treatments. Lifestyle changes are crucial for managing these conditions and preventing frailty.
Area of Science:
- Lipidology
- Endocrinology
- Geriatrics
Background:
- HIV infection triggers inflammation and microbial translocation, leading to dyslipidemia and insulin resistance.
- Antiretroviral therapy (ART) incompletely reverses these metabolic changes, with protease inhibitors posing the greatest lipid risks.
- Genetic factors significantly influence dyslipidemia in HIV-infected individuals.
Purpose of the Study:
- To review recent advancements in understanding lipids, diabetes, and body fat changes in aging HIV-infected patients.
- To highlight the impact of HIV and ART on metabolic health and aging.
- To discuss the implications for patient comorbidities and frailty.
Main Methods:
- Literature review of recent studies on HIV, lipids, diabetes, and aging.
- Analysis of the effects of different antiretroviral drug classes on lipid profiles.
- Examination of the relationship between lipodystrophy, inflammation, and metabolic dysfunction.
Main Results:
- HIV-associated inflammation and dyslipidemia contribute to atherosclerosis and insulin resistance.
- Certain ARTs (etravirine, maraviroc, raltegravir) show better lipid profiles than others.
- Lipodystrophy, including lipohyperpertrophy, is increasingly prevalent and linked to inflammation, metabolic disorders, and functional decline.
Conclusions:
- Aging individuals with HIV face elevated risks of comorbidities and frailty due to persistent inflammation, cholesterol abnormalities, and lipodystrophy from HIV and ART.
- Proactive lifestyle interventions and targeted strategies are essential to mitigate these metabolic abnormalities and promote health in aging HIV populations.
More Related Videos
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
12.2K
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
18.6K
Related Concept Videos
01:29Pulmonary Tuberculosis I
1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
01:10Retrovirus Life Cycles
43.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
01:24Chronic Kidney Disease II: Clinical Manifestations
1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
01:24Overview of Lipid Metabolism
6.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.9K
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
01:19Overview of Carbohydrate Metabolism
4.5K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.5K